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Lithium Neurotoxicity at
Normal Serum Levels
To the Editor: Lithium is used with
great success in the treatment and
prophylaxis of bipolar disorders,
unipolar recurrent depression, and
endogenous depression that is
resistant to conventional treatment.
It is also known to be neurotoxic at
higher serum levels. In rare cases
patients develop symptoms of
intoxication even with normal lith-
ium levels.1
Case Report
A 61-year-old man with history of
bipolar disorder that was managed
with lithium for more than 20
years presented with complaints of
psychomotor slowdown, unsteady
gait, memory deficits, restlessness,
sleep disorder, and severe tremor
in his hand that prevented him
from eating or drinking properly.
These symptoms had begun in the
previous week. There was no
recent history of fever, respiratory,
gastrointestinal, or urinary com-
plaints. He was medicated with
lithium, 800 mg/day, and fluvox-
amine, 200 mg/day, and the
dosage of his medication had
remained unchanged over the last
year.
Neurological examination
showed psychomotor slowdown,
inattention, temporal disorienta-
tion, severe episodic memory
impairment, motor and verbal per-
severation, slurred speech, and
hypophonia. Symmetrical global
and segmental bradykinesia and
lead-pipe rigidity, as well as tremor
at rest, intention, and posture, were
also evident. His gait was abnor-
mal with shuffling small steps and
a hunched-forward upper body.
An analytic study revealed no
abnormalities, including CBC,
renal, thyroid and hepatic function,
and PCR. Lithium serum levels
were normal (1.0 mmol/liter).
EEG showed diffuse slow back-
ground activity, mainly at 5–6 Hz,
with periods of greater lentification
at 3 Hz, which is compatible with
moderate to severe encephalopa-
thy. A brain CT was normal. The
patient was admitted and lithium
was stopped. There was remark-
able clinical improvement over the
next days, and he was discharged
at day 5, asymptomatic and on val-
proic acid (300 mg/day).
Discussion
Lithium-induced neuropsychiatric
symptoms can be polymorphous
and may be hard to differentiate
from other disorders and other
drug side effects.2 In chronic lith-
ium intoxications, gastrointestinal
symptoms are minimal or absent,
and neurological abnormalities
appear in the early phases.3
Increased toxicity in chronic lith-
ium poisoning compared with
other patterns of lithium exposure
has been reported and is likely to
be associated with higher tissue
concentrations, which might not be
readily discernable from serum
lithium measurements alone.4 Sev-
eral reports demonstrate a closer
relationship between neurotoxic
symptoms with EEG changes than
with serum levels of lithium.5 In
our patient the EEG was the only
subsidiary examination indicating
intoxication.
This case highlights the need for
suspecting lithium-induced neuro-
toxicity based on the presence of
clinical features of toxicity rather
than laboratory investigations
alone, as this can occur even at
normal lithium serum levels.
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